185 related articles for article (PubMed ID: 30558808)
1. Systematic review of current prognostication systems for pancreatic neuroendocrine neoplasms.
Teo RYA; Teo TZ; Tai DWM; Tan DM; Ong S; Goh BKP
Surgery; 2019 Apr; 165(4):672-685. PubMed ID: 30558808
[TBL] [Abstract][Full Text] [Related]
2. Validation and comparison between current prognostication systems for pancreatic neuroendocrine neoplasms: A single-institution experience with 176 patients.
Teo R; Goh BKP; Tai DWM; Allen JC; Lim TKH; Hwang JSG; Tan DM; Lee SY; Chan CY; Cheow PC; Chow PKH; Ooi LLPJ; Chung AYF; Ong S
Surgery; 2017 May; 161(5):1235-1245. PubMed ID: 28111046
[TBL] [Abstract][Full Text] [Related]
3. Validation of five contemporary prognostication systems for primary pancreatic endocrine neoplasms: results from a single institution experience with 61 surgically treated cases.
Goh BK; Chow PK; Tan YM; Cheow PC; Chung YF; Soo KC; Wong WK; Ooi LL
ANZ J Surg; 2011 Jan; 81(1-2):79-85. PubMed ID: 21299804
[TBL] [Abstract][Full Text] [Related]
4. Improving survival prognostication of gastroenteropancreatic neuroendocrine neoplasms: Revised staging criteria.
Martin JA; Warner RR; Wisnivesky JP; Kim MK
Eur J Cancer; 2017 May; 76():197-204. PubMed ID: 28334622
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.
Farrell JM; Pang JC; Kim GE; Tabatabai ZL
Cancer Cytopathol; 2014 Oct; 122(10):770-8. PubMed ID: 25044931
[TBL] [Abstract][Full Text] [Related]
6. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
8. Modified Staging Classification for Pancreatic Neuroendocrine Tumors on the Basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems.
Luo G; Javed A; Strosberg JR; Jin K; Zhang Y; Liu C; Xu J; Soares K; Weiss MJ; Zheng L; Wolfgang CL; Cives M; Wong J; Wang W; Sun J; Shao C; Wang W; Tan H; Li J; Ni Q; Shen L; Chen M; He J; Chen J; Yu X
J Clin Oncol; 2017 Jan; 35(3):274-280. PubMed ID: 27646952
[TBL] [Abstract][Full Text] [Related]
9. A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram.
Ellison TA; Wolfgang CL; Shi C; Cameron JL; Murakami P; Mun LJ; Singhi AD; Cornish TC; Olino K; Meriden Z; Choti M; Diaz LA; Pawlik TM; Schulick RD; Hruban RH; Edil BH
Ann Surg; 2014 Feb; 259(2):204-12. PubMed ID: 23673766
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumors: A Retrospective Nationwide Multicenter Study in South Korea.
Cho JH; Ryu JK; Song SY; Hwang JH; Lee DK; Woo SM; Joo YE; Jeong S; Lee SO; Park BK; Cheon YK; Han J; Kim TN; Lee JK; Moon SH; Kim H; Park ET; Hwang JC; Kim TH; Jeon TJ; Cho CM; Choi HS; Lee WJ
Pancreas; 2016 Aug; 45(7):941-6. PubMed ID: 26765964
[TBL] [Abstract][Full Text] [Related]
11. AACE/ACE disease state clinical review: pancreatic neuroendocrine incidentalomas.
Herrera MF; Åkerström G; Angelos P; Grant CS; Hoff AO; Pantoja JP; Pérez-Johnston R; Sahani DV; Wong RJ; Randolph G
Endocr Pract; 2015 May; 21(5):546-53. PubMed ID: 25962093
[TBL] [Abstract][Full Text] [Related]
12. Gastroenteropancreatic neuroendocrine neoplasms: selected pathology review and molecular updates.
Chai SM; Brown IS; Kumarasinghe MP
Histopathology; 2018 Jan; 72(1):153-167. PubMed ID: 29239038
[TBL] [Abstract][Full Text] [Related]
13. Systematic review of current prognostication systems for primary gastrointestinal stromal tumors.
Khoo CY; Chai X; Quek R; Teo MCC; Goh BKP
Eur J Surg Oncol; 2018 Apr; 44(4):388-394. PubMed ID: 29422251
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic Contact Between T and N Classifications in Resected Well-Moderately Differentiated Locoregional Pancreatic Neuroendocrine Neoplasms.
Xu JZ; Wang WQ; Zhang SR; Xu HX; Wu CT; Qi ZH; Gao HL; Ni QX; Liu L; Yu XJ
Ann Surg Oncol; 2018 Mar; 25(3):647-654. PubMed ID: 29235006
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the World Health Organization 2010 grading system in surgical outcome and prognosis of pancreatic neuroendocrine tumors.
Yang M; Tian BL; Zhang Y; Su AP; Yue PJ; Xu S; Wang L
Pancreas; 2014 Oct; 43(7):1003-8. PubMed ID: 24945681
[TBL] [Abstract][Full Text] [Related]
16. Ki-67 labeling: a more sensitive indicator of malignant phenotype than mitotic count or tumor size?
Lowe K; Khithani A; Liu E; Winston T; Christian D; Saad J; Jeyarajah DR
J Surg Oncol; 2012 Nov; 106(6):724-7. PubMed ID: 22549809
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.
Sugimoto M; Takagi T; Hikichi T; Suzuki R; Watanabe K; Nakamura J; Kikuchi H; Konno N; Waragai Y; Asama H; Takasumi M; Watanabe H; Obara K; Ohira H
World J Gastroenterol; 2015 Jul; 21(26):8118-24. PubMed ID: 26185384
[TBL] [Abstract][Full Text] [Related]
18. Comparison of WHO 2000 and WHO 2010 classifications of gastroenteropancreatic neuroendocrine tumors.
Karakuş E; Helvacı A; Ekinci O; Dursun A
Turk J Gastroenterol; 2014 Feb; 25(1):81-7. PubMed ID: 24918137
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine tumor G3: a pancreatic well-differentiated neuroendocrine tumor with a high proliferative rate.
Tanaka H; Matsusaki S; Baba Y; Isono Y; Kumazawa H; Sase T; Okano H; Saito T; Mukai K; Kaneko H
Clin J Gastroenterol; 2015 Dec; 8(6):414-20. PubMed ID: 26439620
[TBL] [Abstract][Full Text] [Related]
20. Colon Neuroendocrine Tumors: A New Lymph Node Staging Classification.
Fields AC; McCarty JC; Lu P; Vierra BM; Pak LM; Irani J; Goldberg JE; Bleday R; Chan J; Melnitchouk N
Ann Surg Oncol; 2019 Jul; 26(7):2028-2036. PubMed ID: 30927196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
